Adaptive BiotechnologiesADPT
那斯達克 · USD
10.33
+0.09
(+0.88%)
收盤 08/02 03:59 (UTC+8)
盤後
10.14
10.14
(-1.84%)
08/02 03:59 (UTC+8)
Adaptive BiotechnologiesADPT
10.33
+0.09
(+0.88%)
財務數據
損益表
- 0.55
- 0.38
- 0.49
- 0.38
- 0.46
- 0.42
- 0.43
- 0.46
- 0.47
- 0.52
- 15.40
- -31.80
- 29.96
- -22.50
- 20.74
- -8.54
- 3.15
- 7.51
- 2.21
- 10.50
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 52,443 | 47,459 | 46,435 | 43,190 | 41,873 | 45,784 | 37,919 | 48,926 | 37,647 | 55,198 |
營業成本 | 16,979 | 18,045 | 16,667 | 19,317 | 18,051 | 19,616 | 19,346 | 17,910 | 18,681 | 16,589 |
營業毛利 | 35,464 | 29,414 | 29,768 | 23,873 | 23,822 | 26,168 | 18,573 | 31,016 | 18,966 | 38,609 |
營業費用 | 65,068 | - | - | 71,191 | - | 97,236 | 69,529 | 78,834 | 76,159 | 77,795 |
研發費用 | 24,203 | 23,192 | 24,163 | 25,353 | 30,245 | 28,746 | 28,533 | 32,237 | 32,601 | 31,222 |
推銷及管理費用 | 40,446 | 39,631 | 37,809 | 38,209 | 41,916 | 42,632 | 40,568 | 46,174 | 43,139 | 46,144 |
非經常性項目費用 | - | - | - | 7,205 | - | 25,429 | - | - | - | - |
其他營業費用 | 419 | 428 | 428 | 424 | 423 | 429 | 428 | 423 | 419 | 429 |
營業利益 | -29,604 | -33,837 | -32,632 | -47,318 | -48,762 | -71,068 | -50,956 | -47,818 | -57,193 | -39,186 |
其他收入及費用 | 2,679 | 3,072 | 3,474 | 3,766 | 4,222 | 4,613 | 4,282 | 3,612 | 3,024 | 2,602 |
利息費用 | 2,905 | 2,952 | 2,939 | 2,696 | 2,993 | 3,012 | 3,652 | 3,605 | 3,531 | 3,585 |
稅前純益 | -29,830 | -33,717 | -32,097 | -46,248 | -47,533 | -69,467 | -50,326 | -47,811 | -57,700 | -40,169 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -29,852 | -33,692 | -32,071 | -46,222 | -47,507 | -69,441 | -50,300 | -47,810 | -57,699 | -40,128 |
基本每股稅後盈餘(元) | -0.20 | -0.23 | -0.22 | -0.31 | -0.33 | - | -0.35 | -0.33 | -0.40 | -0.28 |
稀釋每股稅後盈餘(元) | -0.20 | -0.22 | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.40 | -0.28 |
基本平均股數(千股) | 149195.00 | 147677.00 | 147516.00 | 147414.00 | 145787.00 | - | 144704.00 | 144397.00 | 143511.00 | 143054.00 |
稀釋平均股數(千股) | 149195.00 | 147677.00 | 147516.00 | 147414.00 | 145787.00 | - | 144704.00 | 144397.00 | 143511.00 | 143054.00 |
還原基本每股稅後盈餘(元) | -0.20 | -0.23 | -0.22 | -0.31 | -0.33 | - | -0.35 | -0.33 | -0.40 | -0.28 |
還原稀釋每股稅後盈餘(元) | -0.20 | -0.22 | -0.22 | -0.31 | -0.33 | -0.48 | -0.35 | -0.33 | -0.40 | -0.28 |
還原基本平均股數(千股) | 149,195 | 147,677 | 147,516 | 147,414 | 145,787 | - | 144,704 | 144,397 | 143,511 | 143,054 |
還原稀釋平均股數(千股) | 149,195 | 147,677 | 147,516 | 147,414 | 145,787 | - | 144,704 | 144,397 | 143,511 | 143,054 |
EBITDA(千元) | -23,174 | -27,750 | -26,549 | -40,622 | -41,943 | -63,996 | -43,583 | -40,470 | -50,354 | -32,341 |